
First commercial kidney transplant in Australia using Hansa's Idefirix treatment marks a key milestone.
Hansa Biopharma announced the first commercial living donor kidney transplant in Australia using Idefirix (imlifidase), a treatment that helps highly sensitized patients overcome immune barriers to transplantation. This milestone is significant as it...

